Target discovery for T cell therapy: next steps to advance Immunotherapies

Investigators from academia and industry gathered on August 14, 2014, in Boston at the Inaugural ImVacS conference entitled "Target Discovery for T Cell Therapy: Next Step to Advance Immunotherapies". Novel targets, discovery strategies and enabling technologies were presented and discusse...

Full description

Saved in:
Bibliographic Details
Published inJournal for immunotherapy of cancer Vol. 3; no. 1
Main Authors Bot, Adrian, Brewer, Joanna E, Eshhar, Zelig, Frankel, Stanley R, Hickman, Emma, Jungbluth, Achim A, Morgan, Richard, Peretz, Yoav, Radvanyi, Laszlo, Ramos, Carlos A, Robbins, Paul F, Wucherpfennig, Kai W
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 21.07.2015
BMJ Publishing Group LTD
BioMed Central
Subjects
Antigens
B cells
Cancer
Cancer therapies
Genetic aspects
Health aspects
Immunoglobulins
Immunotherapy
Lymphocytes
Meeting Report
Patient safety
Peptides
Physiological aspects
Protein expression
Proteins
Reagents
T cell receptors
T cells
Target recognition
Tumors
Vaccines
Online AccessGet full text

Cover

More Information
Summary:Investigators from academia and industry gathered on August 14, 2014, in Boston at the Inaugural ImVacS conference entitled "Target Discovery for T Cell Therapy: Next Step to Advance Immunotherapies". Novel targets, discovery strategies and enabling technologies were presented and discussed. Keywords: Immunotherapy, Adoptive T cell therapy, Chimeric antigen receptors, T cell receptors, Tumor infiltrating lymphocytes, Targets, Adoptive T cell therapy, Antibodies, Vaccines
ISSN:2051-1426
2051-1426
DOI:10.1186/s40425-015-0061-5